Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03145701 · ClinicalTrials.gov registry record
Doppler Flow Wires in Cerebral Angiography
A clinical trial of Aneurysm and Cerebral Aneurysm, sponsored by University of Washington.
- Completed
- Registry status
- 117
- Enrollment target
- 1
- Study location
NCT03145701: Completed study of Aneurysm and Cerebral Aneurysm, sponsored by University of Washington.
NCT03145701 is a study of Aneurysm and Cerebral Aneurysm that has completed, run by University of Washington. The registered enrollment target is 117 participants, below the 17,077-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03145701, a study of Aneurysm and Cerebral Aneurysm, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a wire with a Doppler tip to measure blood flow in vessels in the brain and determine hemodynamic factors associated with treatment success or failure. Many neurological diseases cause abnormal blood flow in the brain in specific vessels. The special wire used in this study is place into brain blood vessels during standard of care procedure to treat such diseases, and blood flow parameters (such as velocity and pressure) are measured to gain better understanding of these neurological diseases.
Primary Outcome
The results of this prospective aim have the potential to substantially influence aneurysm management by predicting long-term outcome at the time of initial treatment. The investigators will determine how well the prospective test predicts long-term treatment success as applied at the time of treatment, using computational fluid dynamics modeling of hemodynamic factors with the incorporation of patient-specific measurements obtained by the Doppler guidewire
Conditions Studied
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2020-06-01 |
What the finished NCT03145701 record still lists
NCT03145701 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 17,077-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT03145701 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03145701 about?
NCT03145701 is a clinical study titled "Doppler Flow Wires in Cerebral Angiography". The purpose of this study is to use a wire with a Doppler tip to measure blood flow in vessels in the brain and determine hemodynamic factors associated with treatment success or failure. Many neurological diseases cause abnormal blood flow in the brain in specific vessels. The special wire used in ...
What is the current status of trial NCT03145701?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2020-06-01. Estimated completion is 2020-06-01.
What conditions does trial NCT03145701 study?
This clinical trial studies the following conditions: Aneurysm, Cerebral Aneurysm.
Who is sponsoring clinical trial NCT03145701?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03145701 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
RECRUITING · NA
-
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
RECRUITING
-
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
RECRUITING · NA
-
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI